Not Otherwise Classified J Code: J0799
Fda approved prescription drug, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv), not otherwise classified
Drug & Product Overview
About Not Otherwise Classified
Not Otherwise Classified is a medication aligned to the HCPCS J Code: J0799 for billing, pricing, and reimbursement purposes in the United States. It is an Anti-HIV drug.
Manufacturers, reach out to us to add more information.
NDC Code Information
No NDC packages are aligned to J0799 in publicly available CMS files.
| NDC Code | Drug | Manufacturer | Billing Units / Pkg | Package Size |
|---|---|---|---|---|
| No public NDC alignments | ||||
Not Otherwise Classified Pricing & Reimbursement
National median reimbursement across major commercial payers.
Create an account on PayerPrice for more information →This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →
Login for BuyandBill.com Analytics
Unlock deeper insights with BuyandBill’s Comparative Report!
- Compare ASP, WAC, and AWP across drugs.
- Visualize Drug Price Movement Over Time
- Tailor reports to drug class, manufacturer, or HCPCS Code.
- Compare Biosimilar and 505(b)(2) products.
Frequently Asked Questions
Is there an available Not Otherwise Classified billing and coding guide?
Are there any available Not Otherwise Classified patient assistance programs?
Where can I find Not Otherwise Classified prescribing information?
Where can I find Not Otherwise Classified side effect information?
Does billing Not Otherwise Classified require JZ/JW wastage modifiers?
About BuyandBill.com:
The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.
Related Drug Codes
Explore billing, coding, and pricing for drugs related to Not Otherwise Classified.